India’s Antibiotic Use Skewed Towards Powerful Drugs, Lancet Study Warns — What It Means for Common Infections

A major international study published in The Lancet Public Health has found that India is over-relying on powerful “Watch” category antibiotics, while under-using first-line “Access” antibiotics — a pattern experts say points to both overuse and misuse of critical drugs, and raises concerns about antimicrobial resistance.

The WHO’s AWaRe framework divides antibiotics into three groups: Access drugs, narrow-spectrum options meant to be the first or second choice for common infections; Watch drugs, broader-spectrum antibiotics with higher resistance potential that should be reserved for specific cases; and Reserve drugs, last-resort options meant only for when nothing else works.

The Numbers

According to the study, India’s overall antibiotic consumption stands at 18.3 defined daily doses per 1,000 people per day (DID), higher than the estimated ideal of 14.7 DID. The imbalance lies in how that usage is distributed: Access-antibiotic use is only 4.5 DID against an estimated need of 7.8 DID, while Watch-antibiotic use runs at 9.3 DID — well above the recommended 6 DID.

Per the report referenced, only about 27% of antibiotic use in India falls into the ideal Access category, far short of the roughly 52% target the WHO considers appropriate, with Watch antibiotics dominating prescriptions instead. The study also flagged that some older antibiotics no longer recommended for common use are still being prescribed more often than expected.

Why It Matters

Overuse of Watch and Reserve antibiotics accelerates antimicrobial resistance (AMR) — a phenomenon where bacteria evolve to resist the drugs designed to kill them. This raises the risk that infections which are currently treatable with simple, low-cost antibiotics could become harder — or in some cases impossible — to treat with existing medicines, forcing doctors to turn to stronger, more expensive, and more toxic drugs.

What Experts Recommend

Health experts cited in coverage of the study point to a few key fixes: strengthening antibiotic stewardship programs in hospitals and clinics, ensuring better diagnostic testing before antibiotics are prescribed (rather than empirical or precautionary prescribing), and tightening controls specifically around Reserve-category drugs to keep them as a true last line of defense.

The findings add to a growing body of research — including earlier Lancet studies — that has flagged India’s antibiotic consumption patterns as a persistent concern in the global fight against drug-resistant infections.

This is a sensitive public health topic — for guidance on antibiotic use, always consult a qualified doctor rather than self-medicating.

Suggested tags:

Lancet study, antibiotic resistance, antimicrobial resistance, India health news, AWaRe classification, Watch antibiotics, Access antibiotics, antibiotic overuse, public health India, drug resistance, WHO antibiotic guidelines, healthcare India, infection treatment